|
|
.
See Category: Neoplasms
See Header: Squamous cell carcinoma skin/ upper limb, including shoulder
ICD-10 (CM) Code and Descriptor
|
C44.629 |
Squamous cell carcinoma of skin of left upper limb, including shoulder
|
C44629 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 58.52%
|
21.59%
|
7.52%
|
3.45%
|
2.42%
|
1.73%
|
1.16%
|
0.92%
|
0.62%
|
0.59%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C44.629*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
8,156
|
10,263
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,992
|
3,006
|
|
12032
|
INTMD RPR S/A/T/EXT 2.6-7.5 |
1,442
|
1,443
|
|
11602
|
EXC TR-EXT MAL+MARG 1.1-2 CM |
1,242
|
1,254
|
|
11102
|
TANGNTL BX SKIN SINGLE LES |
1,191
|
1,191
|
|
77412
|
RADIATION TX DELIVERY COMPLX |
1,176
|
1,176
|
|
17311
|
MOHS 1 STAGE H/N/HF/G |
1,102
|
1,141
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
808
|
21,278
|
|
17000
|
DESTRUCT PREMALG LESION |
765
|
765
|
|
11603
|
EXC TR-EXT MAL+MARG 2.1-3 CM |
726
|
735
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
689
|
2,547
|
|
J3010
|
FENTANYL CITRATE INJECTION |
656
|
900
|
|
17003
|
DESTRUCT PREMALG LES 2-14 |
651
|
1,738
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
611
|
612
|
|
17313
|
MOHS 1 STAGE T/A/L |
578
|
607
|
|
88331
|
PATH CONSLTJ SURG 1 BLK 1SPC |
507
|
660
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
501
|
501
|
|
J2405
|
ONDANSETRON HCL INJECTION |
481
|
1,953
|
|
13121
|
CMPLX RPR S/A/L 2.6-7.5 CM |
464
|
464
|
|
11606
|
EXC TR-EXT MAL+MARG >4 CM |
463
|
464
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C44.629 related to the following DRG Codes:
606-607
|
